Cargando…

Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays

BACKGROUND: Plasmodium falciparum in vitro growth inhibition assays are widely used to evaluate and quantify the functional activity of acquired and vaccine-induced antibodies and the anti-malarial activity of known drugs and novel compounds. However, several constraints have limited the use of thes...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Danny W, Crabb, Brendan S, Beeson, James G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891815/
https://www.ncbi.nlm.nih.gov/pubmed/20525251
http://dx.doi.org/10.1186/1475-2875-9-152
_version_ 1782182903885594624
author Wilson, Danny W
Crabb, Brendan S
Beeson, James G
author_facet Wilson, Danny W
Crabb, Brendan S
Beeson, James G
author_sort Wilson, Danny W
collection PubMed
description BACKGROUND: Plasmodium falciparum in vitro growth inhibition assays are widely used to evaluate and quantify the functional activity of acquired and vaccine-induced antibodies and the anti-malarial activity of known drugs and novel compounds. However, several constraints have limited the use of these assays in large-scale population studies, vaccine trials and compound screening for drug discovery and development. METHODS: The D10 P. falciparum line was transfected to express green fluorescent protein (GFP). In vitro growth inhibition assays were performed over one or two cycles of P. falciparum asexual replication using inhibitory polyclonal antibodies raised in rabbits, an inhibitory monoclonal antibody, human serum samples, and anti-malarials. Parasitaemia was evaluated by microscopy and flow cytometry. RESULTS: Transfected parasites expressed GFP throughout all asexual stages and were clearly detectable by flow cytometry and fluorescence microscopy. Measurement of parasite growth inhibition was the same when determined by detection of GFP fluorescence or staining with ethidium bromide. There was no difference in the inhibitory activity of samples when tested against the transfected parasites compared to the parental line. The level of fluorescence of GFP-expressing parasites increased throughout the course of asexual development. Among ring-stages, GFP-fluorescent parasites were readily separated from uninfected erythrocytes by flow cytometry, whereas this was less clear using ethidium bromide staining. Inhibition by serum and antibody samples was consistently higher when tested over two cycles of growth compared to one, and when using a 1 in 10 sample dilution compared to 1 in 20, but there was no difference detected when using a different starting parasitaemia to set-up growth assays. Flow cytometry based measurements of parasitaemia proved more reproducible than microscopy counts. CONCLUSIONS: Flow cytometry based assays using GFP-fluorescent parasites proved sensitive and highly reproducible for quantifying the growth-inhibitory activity of antibodies and anti-malarials, with superior reproducibility to light microscopy, and are suitable for high-throughput applications.
format Text
id pubmed-2891815
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28918152010-06-25 Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays Wilson, Danny W Crabb, Brendan S Beeson, James G Malar J Methodology BACKGROUND: Plasmodium falciparum in vitro growth inhibition assays are widely used to evaluate and quantify the functional activity of acquired and vaccine-induced antibodies and the anti-malarial activity of known drugs and novel compounds. However, several constraints have limited the use of these assays in large-scale population studies, vaccine trials and compound screening for drug discovery and development. METHODS: The D10 P. falciparum line was transfected to express green fluorescent protein (GFP). In vitro growth inhibition assays were performed over one or two cycles of P. falciparum asexual replication using inhibitory polyclonal antibodies raised in rabbits, an inhibitory monoclonal antibody, human serum samples, and anti-malarials. Parasitaemia was evaluated by microscopy and flow cytometry. RESULTS: Transfected parasites expressed GFP throughout all asexual stages and were clearly detectable by flow cytometry and fluorescence microscopy. Measurement of parasite growth inhibition was the same when determined by detection of GFP fluorescence or staining with ethidium bromide. There was no difference in the inhibitory activity of samples when tested against the transfected parasites compared to the parental line. The level of fluorescence of GFP-expressing parasites increased throughout the course of asexual development. Among ring-stages, GFP-fluorescent parasites were readily separated from uninfected erythrocytes by flow cytometry, whereas this was less clear using ethidium bromide staining. Inhibition by serum and antibody samples was consistently higher when tested over two cycles of growth compared to one, and when using a 1 in 10 sample dilution compared to 1 in 20, but there was no difference detected when using a different starting parasitaemia to set-up growth assays. Flow cytometry based measurements of parasitaemia proved more reproducible than microscopy counts. CONCLUSIONS: Flow cytometry based assays using GFP-fluorescent parasites proved sensitive and highly reproducible for quantifying the growth-inhibitory activity of antibodies and anti-malarials, with superior reproducibility to light microscopy, and are suitable for high-throughput applications. BioMed Central 2010-06-03 /pmc/articles/PMC2891815/ /pubmed/20525251 http://dx.doi.org/10.1186/1475-2875-9-152 Text en Copyright ©2010 Wilson et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology
Wilson, Danny W
Crabb, Brendan S
Beeson, James G
Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays
title Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays
title_full Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays
title_fullStr Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays
title_full_unstemmed Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays
title_short Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays
title_sort development of fluorescent plasmodium falciparum for in vitro growth inhibition assays
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891815/
https://www.ncbi.nlm.nih.gov/pubmed/20525251
http://dx.doi.org/10.1186/1475-2875-9-152
work_keys_str_mv AT wilsondannyw developmentoffluorescentplasmodiumfalciparumforinvitrogrowthinhibitionassays
AT crabbbrendans developmentoffluorescentplasmodiumfalciparumforinvitrogrowthinhibitionassays
AT beesonjamesg developmentoffluorescentplasmodiumfalciparumforinvitrogrowthinhibitionassays